Rodenstock Group has announced its results for the financial year 2023. The group increased consolidated pro-forma net sales to €506.1 million, driven by continued strong sales growth of its B.I.G. VISION product portfolio of biometric progressive lenses and the successful launch of MyCon lenses for children. Read More